Home › Membranous Glomerulonephritis › Washington
Membranous Glomerulonephritis clinical trials in Washington, DC
3 studies for Membranous Glomerulonephritis are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
RecruitingPhase 2
- National Naval Medical Center, Bethesda · 7 mi away
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Belimumab With Rituximab for Primary Membranous Nephropathy
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Membranous Glomerulonephritis trials in other cities
- Ann Arbor, MI3 studies
- Philadelphia, PA3 studies
- Cleveland, OH3 studies
- New York City, NY3 studies
- Spokane, WA3 studies
- Durham, NC3 studies
- Baltimore, MD3 studies
- Miami, FL3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.